Gallbladder cancer — expert surgery, explained clearly

Gallbladder cancer is a malignant tumour arising from the inner lining of the gallbladder. It is the most common biliary tract cancer and tends to be more prevalent in parts of South Asia, including India. The gallbladder sits beneath the liver in the upper right abdomen, storing bile produced by the liver. When cancer arises here, it can remain silent for a long time — which is one reason it can catch both patients and doctors by surprise.

A particularly important pattern in gallbladder cancer is incidental discovery: the cancer is found on the histology (pathology) report after a laparoscopic cholecystectomy (keyhole gallbladder removal) carried out for what appeared to be straightforward gallstones. In these cases, the patient believed they were having a routine operation — and then the laboratory report reveals cancer in the gallbladder wall. This is called incidental gallbladder cancer (IGBC), and it requires prompt specialist reassessment.

When gallbladder cancer grows beyond its early stages, it can spread to the adjacent liver bed (the tissue on the underside of the liver), nearby bile ducts, and regional lymph nodes. Staging this spread accurately — and acting promptly — is central to achieving the best outcome.

Early gallbladder cancer typically causes no symptoms at all. This is why so many cases are found incidentally, either after surgery for gallstones or on imaging performed for an unrelated problem. When symptoms do appear, they often reflect more advanced disease:

• Upper right abdominal pain — persistent discomfort or aching beneath the right ribcage
• Jaundice — yellowing of the skin or whites of the eyes, indicating bile duct involvement
• Unintentional weight loss — losing weight without trying
• Nausea and loss of appetite
• A palpable lump in the upper abdomen in some cases
• An unexpected cancer report after cholecystectomy — the most important red flag: if your gallbladder removal histology report mentions dysplasia, carcinoma in situ, or adenocarcinoma, you need urgent specialist review

If you have received a histology report following gallbladder removal that mentions cancer — even an early stage — please seek a specialist HPB surgical opinion promptly. Time matters.

The exact cause of gallbladder cancer is not fully understood, but several well-established risk factors are associated with its development:

• Gallstones (cholelithiasis) — long-standing gallstones, particularly large stones (>3 cm), are the most common associated risk factor; chronic irritation from stones is thought to drive malignant change over time
• Gallbladder polyps — polyps larger than 1 cm, sessile polyps, or rapidly growing polyps carry a meaningful risk of malignancy and usually warrant cholecystectomy
• Porcelain gallbladder — calcification of the gallbladder wall (historically thought to carry high risk; evidence now more nuanced, but incomplete calcification patterns warrant specialist review)
• Chronic gallbladder inflammation — including chronic cholecystitis, primary sclerosing cholangitis, and anomalous pancreaticobiliary duct junction
• Female sex and older age — gallbladder cancer is more common in women and increases with age
• Geography and ethnicity — rates are higher in parts of North India, South America, and East Asia

Diagnosis typically involves a combination of imaging, blood tests, and pathology. The approach depends on how the cancer presents:

• Ultrasound — often the first investigation; can identify gallbladder wall thickening, masses, or polyps
• Contrast-enhanced CT scan — essential for staging; assesses local extension, liver involvement, lymph nodes, and distant spread
• MRI / MRCP — particularly useful when bile duct involvement is suspected
• Review of prior cholecystectomy histology — for incidental cases, the pathology report from the removed gallbladder is the starting point; the T-stage (depth of invasion) drives subsequent management
• CA 19-9 and CEA — tumour markers that can support the diagnosis and help monitor response, though neither is diagnostic alone
• Multidisciplinary tumour board (MDT) — all cases are discussed at a specialist tumour board before a treatment plan is finalised, bringing together HPB surgery, oncology, radiology, and pathology

Surgery is the only curative treatment for gallbladder cancer, and the extent of surgery required depends on the stage of the cancer.

• Radical (extended) cholecystectomy — the standard curative operation for resectable gallbladder cancer. This involves removing the gallbladder together with a wedge (margin) of adjacent liver tissue (the gallbladder bed) and dissecting the regional lymph nodes. Achieving clear surgical margins is the primary goal. In some cases, bile duct resection and reconstruction is also required.
• Re-resection after incidental gallbladder cancer — when cancer is discovered on histology after a simple laparoscopic cholecystectomy, the initial surgery was not designed with oncological margins in mind. Depending on the T-stage (depth of invasion), re-staging and a second, definitive radical re-resection operation is often required. This is a time-sensitive decision that requires HPB surgical expertise.
• Adjuvant chemotherapy — chemotherapy after surgery may be recommended in selected cases, particularly for more advanced-stage resected tumours, and is decided in the multidisciplinary team setting.
• Palliative care — when cancer is diagnosed at an advanced, unresectable stage, the focus shifts to controlling symptoms, managing jaundice (with biliary stenting if needed), and maintaining quality of life. Dr Kumar will always be honest about what surgery can and cannot achieve.

Dr Ameet Kumar is an HPB and GI-oncology surgeon with specific experience in the full spectrum of gallbladder cancer management — from early-stage incidental findings to radical resection for established tumours. His approach combines technical precision with honest, unhurried communication.

• Expert in the incidental-gallbladder-cancer pathway — Dr Kumar is practised in the re-staging and re-resection pathway for incidentally found gallbladder cancer: reviewing the original histology, determining T-stage, organising appropriate cross-sectional imaging, and deciding with the MDT whether and when radical re-resection is required
• Radical cholecystectomy — performs radical (extended) cholecystectomy including liver bed resection and regional lymphadenectomy, with the goal of clear (R0) resection margins
• MDT planning — all cases are reviewed at a multidisciplinary tumour board before surgery; oncology, radiology, and pathology input is integral to every treatment plan
• Honest counselling — Dr Kumar believes in clear, unambiguous conversations about what surgery involves, what it can realistically achieve, and what the alternatives are; you will leave the consultation knowing exactly where you stand
• Consultant — Sakra World Hospital, Devarabeesanahalli, Bengaluru — Dr Kumar sees patients in private practice in Bengaluru; contact details below

Radical cholecystectomy is a significant but well-tolerated operation in fit patients. Patients should have clear expectations before the procedure:

• Hospital stay — typically 4–7 days for radical cholecystectomy, depending on the extent of liver resection and whether bile duct reconstruction was required
• Return to light activity — most patients are mobile and managing daily tasks within 2–4 weeks; full recovery typically takes 6–8 weeks
• Diet — a low-fat diet is advisable in the weeks after surgery; most patients tolerate a normal diet within 4–6 weeks
• Structured follow-up — regular imaging (CT or MRI), tumour marker monitoring (CA 19-9, CEA), and oncology review are arranged to detect any recurrence early and manage it promptly

Outcomes depend on the stage at which the cancer is found and the completeness of surgical resection. Dr Kumar will discuss realistic expectations with you at every stage of the journey.